NAVB Related Analyst Ratings
-
Janney Montgomery Scott Starts Navidea Biopharmaceuticals (NAVB) at Buy
-
Burrill Maintains Positive Stance on Navidea Biopharmaceuticals (NAVB) on FDA Approval
-
Piper Jaffray Starts Navidea Biopharmaceuticals (NAVB) at Underweight
-
Aegis Capital Starts Navidea Biopharmaceuticals (NAVB) at Hold
-
Burrill Starts Navidea Biopharmaceuticals (NAVB) at Market Outperform
-
Dawson James Starts Navidea Biopharmaceuticals (NAVB) at Market Outperform
-
ThinkEquity Downgrades Navidea Biopharmaceuticals (NAVB) to Hold
-
ThinkEquity Starts Navidea Biopharmaceuticals (NAVB) at Buy
Back to NAVB Stock Lookup
